2017 Press Releases Keyword Search Year: 20202019201820172016201520142013 Nov 4, 2010 Summary ToggleAgios Awarded Two Federal Grants to Advance Cancer Metabolism Focused Therapeutics Sep 20, 2010 Summary ToggleAgios Appoints Scott Biller, Ph.D., Industry Leader and Drug Developer, as Chief Scientific Officer Jun 24, 2010 Summary ToggleAgios Appoints John Maraganore, Ph.D., to Board of Directors Apr 15, 2010 Summary ToggleCelgene Corporation and Agios Pharmaceuticals Announce Global Strategic Collaboration to Advance Unique Science of Cancer Metabolism Mar 11, 2010 Summary ToggleAgios Pharmaceuticals Appoints William Kaelin Jr., M.D., to Scientific Advisory Board Dec 21, 2009 Summary ToggleAgios Pharmaceuticals Awarded Funding From Accelerate Brain Cancer Cure (ABC2) to Support Research into Novel Therapeutics and Diagnostics for Brain Cancer Nov 23, 2009 Summary ToggleAgios Publishes Groundbreaking Research in Nature Uncovering the New Role of IDH1 Gene Mutation in Brain Cancer Jun 29, 2009 Summary ToggleFierceBiotech Names Agios Pharmaceuticals as One of the "Fierce 15" Biotech Companies of 2009 May 28, 2009 Summary ToggleAgios Pharmaceuticals' Focus of Drug Research - Cancer Metabolism - Selected for Stand Up To Cancer Grant May 27, 2009 Summary ToggleAgios Pharmaceuticals Appoints David Schenkein, M.D., as CEO and Duncan Higgons as COO Apr 30, 2009 Summary ToggleAgios Pharmaceuticals Highlights Extensive Cancer Metabolism Research at AACR Feb 6, 2009 Summary ToggleAgios Pharmaceuticals Appoints Charles Sawyers, M.D.,to Scientific Advisory Board Nov 24, 2008 Summary ToggleAgios Pharmaceuticals Expands Into 21,000 SqFt Facility Nov 24, 2008 Summary ToggleAgios Pharmaceuticals Attracts Leading Cancer Metabolism Experts to Advisory Team Jul 7, 2008 Summary ToggleAgios Pharmaceuticals Closes $33 Million Series A Funding Pagination First page First Previous page Previous … Page 4 Page 5 Page 6 Current page 7